Indian benchmark indices Nifty 50 and Sensex ended the previous trade session lower. Nifty ended at 22,945.30, while Sensex ...

Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...

Larsen & Toubro (L&T) has acquired the balance 26% stake in L&T Special Steels and Heavy Forgings (LTSSHF), an existing subsidiary of the company, from Nuclear Power Corporation of India (NPCIL) and ...

Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor ...

The observations are mainly procedural and do not indicate any data integrity issues, Piramal Pharma added in a regulatory ...

The company stated that the observations primarily pertain to procedural improvements and are not related to data integrity.

However, the shift of strategic direction to wellness has raised uncertainty over Kirin’s long-term growth prospects, where execution plays a key role in integrating the acquired subsidiary and ...

Total 4Q and full year 2024 net product revenue of $118.8 million and $385.7 million, respectively, representing 66% and 88% year-over-year ...